Paeoniflorin-Copper-Coordinated Nanoparticles Targeting Dual Organelles Induce Lung Cancer Apoptosis
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Jiachang Lin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respira…. Hauptthemen laut MEDLINE: Monoterpenes, Glucosides, Apoptosis, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Bureau, Guangzhou Municipal Science and Technology Project, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
The intrinsic resistance of tumor cells to apoptosis frequently results in chemoresistance and therapeutic failure in clinical settings. The main active ingredients of traditional Chinese medicine, in combination with chemotherapy drugs, have become one of the effective treatment methods to overcome this kind of drug resistance by targeting double subcellular organelles to promote apoptosis. In this study, we developed a Cu2+-coordinated paeoniflorin (PF)/doxorubicin (DOX) biocomplex, referred to as PCD, with the aim of overcoming cellular apoptosis resistance for combinational lung cancer therapy. PCD demonstrates remarkable water solubility and superior in vivo biocompatibility. Owing to the coordination effect, the self-assembled PCD exhibits a nanoscale particle size, a narrow and homogeneous grain distribution, as well as exceptional dispersion stability. Furthermore, PCD has the potential to disassemble under conditions of high glutathione levels and low pH, thereby facilitating effective drug release. PF-mediated endoplasmic reticulum stress (ERS) can downregulate the expression of FDX1 and DLAT proteins. Ca2+ overload induced by ERS disrupts mitochondrial matrix ion balance, accelerates water efflux, and ultimately leads to mitochondrial volume reduction and a decrease in mitochondrial membrane potential. Ultimately, this process synergizes with DOX-induced reactive oxygen species production to enhance apoptosis in lung cancer cells. PCD exhibits significant superiority over monotherapy in inhibiting tumor growth while minimizing systemic toxicity via enhanced induction of lung cancer apoptosis. This study may provide a promising avenue for advancing self-delivery nanomedicine to overcome apoptosis resistance in lung cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, The Fifth Affiliated Hospital, and School of Pharmaceuti…
- Guangdong Pharmaceutical University, Guangzhou, Guangdong 511335, PR China.
- The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510250, PR China.
- The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510235, PR China.
- Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., Guangzhou, Guangdong 510215, PR China.
ORCID-Profile: Yi Zhou
Förderung
- Guangzhou Municipal Science and Technology Bureau
- Guangzhou Municipal Science and Technology Project
- Natural Science Foundation of Guangdong Province
- Guangzhou Municipal Education Bureau's University Research Project
- Student Innovation Ability Improvement Program of Guangzhou Medical University
- Guangzhou Health Science and Technology General Guidance Project
- Guangzhou Medical University Research Capacity Enhancement Project
- Provincial-level Key Laboratory Open subject in Guangzhou Medical University
Zitieren
APA
Lin, J., Huang, P., Wang, Y., Wu, J., Jian, Y., Zhu, L., Wen, H., Gao, W., Miao, Y., Wang, H., Yu, X., Liu, C., & Zhou, Y. (2026). Paeoniflorin-Copper-Coordinated Nanoparticles Targeting Dual Organelles Induce Lung Cancer Apoptosis. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01528
Vancouver
Lin J, Huang P, Wang Y, Wu J, Jian Y, Zhu L, et al. Paeoniflorin-Copper-Coordinated Nanoparticles Targeting Dual Organelles Induce Lung Cancer Apoptosis. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01528
BibTeX
@article{Lin2026,
author = {Lin, Jiachang and Huang, Pei and Wang, Yongqi and Wu, Jiaxiang and Jian, Yushi and Zhu, Lina and Wen, Huaying and Gao, Wenhui and Miao, Yingling and Wang, He and Yu, Xiyong and Liu, Chunfang and Zhou, Yi},
title = {Paeoniflorin-Copper-Coordinated Nanoparticles Targeting Dual Organelles Induce Lung Cancer Apoptosis},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01528}
}
EUVIMED